Clinical

Dataset Information

0

Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients


ABSTRACT: Multicentric randomised trial. Patients with a high risk of developing colorectal Peritoneal Carcinomatosis (PC) after resection of their primary will be informed, will sign the consent and will be pre-registered. All patients will receive the current standard adjuvant treatment : 6 months of systemic chemotherapy (currently the Folfox-4 regimen which could be modified if the standard is modified). Then a work-up is done to exclude recurrence. The likelihood of a recurrence is low but if this occurs, the patient will not be randomised and will be treated with the best known treatment. If the work-up is negative, patients will be randomised to surveillance alone (control group) or exploratory laparotomy + HIPEC (experimental group).

DISEASE(S): Tumour Rupture In The Abdominal Cavity,Ovarian Metastases,Rupture,Colorectal Cancer With A Resected Minimal Synchronous Pc,Colorectal Cancer,Cancers Colorectaux À Très Haut Risque De Développer Une Carcinose Péritonéale,Peritoneal Carcinomatosis,Krukenberg Tumor

PROVIDER: 2096967 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2022-04-28 | GSE201252 | GEO
| PRJNA830506 | ENA
| 2235205 | ecrin-mdr-crc
2019-10-29 | GSE107422 | GEO
2017-03-02 | MTBLS424 | MetaboLights
2011-10-11 | GSE26971 | GEO
| PRJNA776692 | ENA
2022-03-25 | GSE199121 | GEO
| 2424569 | ecrin-mdr-crc
2020-11-18 | GSE161611 | GEO